ArticleOncology reports2026

C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC.

Eunsun Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.